Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
American Journal of Hematology
|
March 12, 1998
Development of rheumatoid arthritis after treatment of large granular lymphocyte leukemia with deoxycoformycin
J Yoe, B L Gause, B D Curti, et al.
Cancer
|
October 1, 1995
Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinoma
F J Esteva-Lorenzo, J E Janik, R G Fenton, et al.
Cancer Research
|
May 15, 1993
Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment
B D Curti, W J Urba, W G Alvord, et al.
The Cancer Journal From Scientific American
|
March 4, 2000
Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia
B Arun, B D Curti, D L Longo, et al.
Cancer
|
November 1, 1993
Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors
J E Janik, M Sznol, W J Urba, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1997
Interleukin 1 alpha increases serum leptin concentrations in humans
J E Janik, B D Curti, R V Considine, et al.
Cancer Investigation
|
July 29, 1998
A phase II study of carboplatin, cisplatin, interferon-alpha, and tamoxifen for patients with metastatic melanoma
B L Gause, W H Sharfman, J E Janik, et al.
The Online Journal of Current Clinical Trials
|
July 1, 1992
Intensive therapy with cisplatin, interleukin-2 and interferon-alpha-2a in patients with metastatic melanoma. A phase II Study
M Sznol, R G Steis, J W Smith, et al.
Journal of the National Cancer Institute
|
January 18, 1995
A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2
J T Holmund, W C Kopp, R H Wiltrout, et al.
The New England Journal of Medicine
|
March 18, 1993
The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin
J W Smith, D L Longo, W G Alvord, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
American Journal of Hematology
|
March 12, 1998
Development of rheumatoid arthritis after treatment of large granular lymphocyte leukemia with deoxycoformycin
J Yoe, B L Gause, B D Curti, et al.
Cancer
|
October 1, 1995
Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinoma
F J Esteva-Lorenzo, J E Janik, R G Fenton, et al.
Cancer Research
|
May 15, 1993
Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment
B D Curti, W J Urba, W G Alvord, et al.
The Cancer Journal From Scientific American
|
March 4, 2000
Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia
B Arun, B D Curti, D L Longo, et al.
Cancer
|
November 1, 1993
Erythropoietin production. A potential marker for interleukin-2/interferon-responsive tumors
J E Janik, M Sznol, W J Urba, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1997
Interleukin 1 alpha increases serum leptin concentrations in humans
J E Janik, B D Curti, R V Considine, et al.
Cancer Investigation
|
July 29, 1998
A phase II study of carboplatin, cisplatin, interferon-alpha, and tamoxifen for patients with metastatic melanoma
B L Gause, W H Sharfman, J E Janik, et al.
The Online Journal of Current Clinical Trials
|
July 1, 1992
Intensive therapy with cisplatin, interleukin-2 and interferon-alpha-2a in patients with metastatic melanoma. A phase II Study
M Sznol, R G Steis, J W Smith, et al.
Journal of the National Cancer Institute
|
January 18, 1995
A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2
J T Holmund, W C Kopp, R H Wiltrout, et al.
The New England Journal of Medicine
|
March 18, 1993
The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin
J W Smith, D L Longo, W G Alvord, et al.
Page
of 4